Revolution Medicines Inc’s (RVMD) Stock: A Week-by-Week Analysis

19h ago, source: newsheater

The stock of Revolution Medicines Inc (RVMD) has gone up by 0.88% for the week, with a 19.00% rise in the past month and a 37.29% rise in the past quarter. The volatility ratio for the week is 6.17%, ...

What's Going On With Revolution Medicines Stock?

on MSN ago, source:

Revolution Medicines, Inc. (NASDAQ:RVMD) shares are trading higher Wednesday. The company announced the publication of ...

Revolution Medicines Receives Buy Rating Amid Promising Cancer Treatment Data and Expanded Market Opportunities

6d ago, source:

Analyst Ami Fadia of Needham maintained a Buy rating on Revolution Medicines (RVMD – Research Report), boosting the price target to ...

Revolution Medicines: An Expensive Shot At A Massive Market Opportunity

6d ago, source:

Revolution is pioneering a unique precision-based approach to developing oncology drugs that target the RAS pathway. Read why ...

Revolution Medicines Inc Ordinary Shares

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Revolution Medicines’ Robust Cancer Drug Pipeline Justifies Buy Rating

10d ago, source:

Analyst Alec Stranahan of Bank of America Securities maintained a Buy rating on Revolution Medicines (RVMD – Research Report), retaining ...

Revolution Medicines executive sells over $619k in company stock

6d ago, source: Investing

Mark A. Goldsmith, a key executive at Revolution Medicines, Inc. (NASDAQ:RVMD), has recently sold a significant amount of company stock, as reported in the latest SEC filings. The transactions ...

Opening a new front against pancreatic cancer

10d ago, source: Science Daily

A new type of investigational therapeutic for pancreatic cancer has shown unprecedented tumor-fighting abilities in preclinical models of the disease.

GV’s Newest Life Sciences General Partner Pursues Precision Treatments

19h ago, source:

The revolution in genetics since the human genome was first sequenced in the early 2000s is making precision treatments ...

Revolution Medicines executive sells over $619k in company stock

6d ago, source: Investing

Mark A. Goldsmith, a key executive at Revolution Medicines, Inc. (NASDAQ:RVMD), has recently sold a significant amount of company stock, as reported in the latest SEC filings. The transactions, which ...

Opening a new front against pancreatic cancer

11d ago, source: EurekAlert!

The inhibitors in this new class of oral medications, being developed by Revolution Medicines Inc., target the oncogenic or active cancer-causing form of RAS proteins (such as KRAS, NRAS ...